Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 72 | 98 | 105 | 1,195 | 256 |
| Gross Profit | 72 | 98 | 105 | 1,195 | 256 |
| Operating Expenses | 59,347 | 72,571 | 49,171 | 30,980 | 29,820 |
| Operating Income | -59,275 | -72,473 | -49,066 | -29,785 | -29,564 |
| Interest Expense | 166 | 165 | 168 | 164 | 154 |
| Other Income | 4,378 | 4,487 | 3,449 | 1,044 | 227 |
| Pre-tax Income | -55,063 | -68,151 | -45,785 | -28,905 | -29,491 |
| Net Income Continuous | -55,063 | -68,151 | -45,785 | -28,905 | -29,491 |
| Net Income | $-55,063 | $-68,151 | $-45,785 | $-28,905 | $-29,491 |
| EPS Basic Total Ops | -1.27 | -1.61 | 0.19 | -0.86 | -1.06 |
| EPS Basic Continuous Ops | -1.27 | -1.61 | -1.15 | -0.86 | -1.06 |
| EPS Diluted Total Ops | -1.27 | -1.61 | 0.19 | -0.86 | -1.06 |
| EPS Diluted Continuous Ops | -1.27 | -1.61 | -1.15 | -0.86 | -1.06 |
| EBITDA(a) | $-62,052 | $-75,343 | $-49,982 | $-29,455 | $-29,247 |